Clinical characteristics and efficacy of short-course antibiotic therapy for <i>Staphylococcus aureus</i> bacteremia in hematological patients

There is still no consensus on the optimal antibiotic course for <i>Staphylococcus aureus</i> bacteremia (SAB) in patients with hematological diseases. Some studies have suggested that short-course antibiotic therapy was feasible for uncomplicated SAB, but few have targeted hematological patients. Here, we described clinical characteristics and outcomes of SAB in hematological patients and highlighted advanced age, refractory or relapsed hematological diseases, and polymicrobial infection as independent predictors of 90-day mortality, while MRSA bacteremia was associated with early mortality risk. And we demonstrated that short-course antibiotic therapy (≤10 days) for uncomplicated SAB in hematological patients was non-inferior to long-course one (>10 days).

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2025-08-12
DOI
https://doi.org/10.1128/spectrum.02325-24
Citations
1
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients

Zhijian Xiao, BeiJun Chen, Yingchang Mi, Qingsong Lin et al.
1 citations
Microbiology Spectrum
Neutropenia and Cancer Infections
1.05
article

Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients

Zhijian Xiao, BeiJun Chen, Yingchang Mi, Qingsong Lin, Hui Wang, Erlie Jiang, Sizhou Feng, Fengkui Zhang, Jianxiang Wang, Xiaomeng Feng, Mingzhe Han, Yizhou Zheng, Nuobing Yang, Lugui Qiu
article en
1 citations

Abstract

There is still no consensus on the optimal antibiotic course for <i>Staphylococcus aureus</i> bacteremia (SAB) in patients with hematological diseases. Some studies have suggested that short-course antibiotic therapy was feasible for uncomplicated SAB, but few have targeted hematological patients. Here, we described clinical characteristics and outcomes of SAB in hematological patients and highlighted advanced age, refractory or relapsed hematological diseases, and polymicrobial infection as independent predictors of 90-day mortality, while MRSA bacteremia was associated with early mortality risk. And we demonstrated that short-course antibiotic therapy (≤10 days) for uncomplicated SAB in hematological patients was non-inferior to long-course one (>10 days).

Microbiology SpectrumVol. 13(9)
Qingdao University (CN), Fujian Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Yuhuangding Hospital (CN), National Clinical Research (US), Fujian Provincial Hospital (CN), Institute of Hematology & Blood Diseases Hospital (CN)
National Natural Science Foundation of China, National Key Research and Development Program of China
Openalex Percentile: Top 19%
Neutropenia and Cancer Infections
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.